CERO THERAPEUTICS HOLDINGS, INC. Gain (Loss) Related to Litigation Settlement
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Gain (Loss) Related to Litigation Settlement of $3.34 million for the 11-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2025-04-15
- CERO THERAPEUTICS HOLDINGS, INC. gain (loss) related to litigation settlement for fiscal 2023 was $8.14K.
| Period end | Gain (Loss) Related to Litigation Settlement 11 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|
| 2024-12-31 | $3.34M 10-K · filed 2025-04-15 | |
| 2023-12-31 | $8.14K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |